Can Xi Jinping Achieve His Ambitions After the Biden-Xi Summit?
By Jianli Yang
Xi’s transformation from “wolf warrior” to “panda” was more about what came after the summit: a major gathering with American CEOs.
Are China’s Healthcare and Biopharma Sectors Really Open for Investment?
By Patrick Beyrer
To attract foreign investment, the Chinese healthcare and biopharma sectors are more open for business than ever – or at least they claim to be. But challenges exist beneath the surface.
Can Economic Ties Continue to Power China-US Relations?
By Shannon Tiezzi
A visit to China by the U.S. commerce secretary saw more deliverables than any other recent exchange, but there are still hard limits on what can be achieved.
Biden Issues Executive Order Restricting US Investments in Chinese Technology
By Josh Boak
The order will block U.S. investments in Chinese companies working on advanced computer chips, micro electronics, quantum information technologies, and artificial intelligence.
US Firms Cannot Ignore the Growing Risks of a Possible China-US Military Conflict
By Sara Hsu
U.S. businesses need to consider the impact of a physical conflict on their Chinese production and distribution bases.
Outlook: China-US Cross-Border Investment
By Mercy A. Kuo
Insights from Jean-Marc F. Blanchard.
Trump Bans US Investment in Chinese Military-Linked Firms
By Associated Press
It is Trump’s first major action toward China since he lost his reelection bid to challenger Joe Biden.